Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05400863 · ClinicalTrials.gov registry record · NA
Effect of NNS on Metformin/GDF15, Pilot
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 46
- Enrollment target
NCT05400863 is a NA study that has completed, run by University of Florida. The registered enrollment target is 46 participants.
The verdict
NCT05400863, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
Study Summary
Metformin use for diabetes has the benefit of causing weight loss in some. The investigators in a preclinical trial, demonstrated that mice consuming non-nutritive sweetened (NNS) drinks had worse glucose improvements and weight loss than mice consuming sugar drinks or water. This study will conduct a pilot to determine if this translates into pediatric clinical practice. The hypothesis is that NNS drinks impair metformin-induced satiation, weight loss, and glucose tolerance.
Interventions
- BEHAVIORAL avoid sugary and NNS drinks plus start Metformin
- BEHAVIORAL avoid sugary drinks (allowed water and drinks sweetened with NNS) plus start Metformin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2022-04-21 |
| Est. Completion | 2024-08-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05400863
The ClinicalTrials.gov registry entry for NCT05400863 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which avoid sugary and NNS drinks plus start Metformin is the first listed.
NCT05400863 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05400863 about?
NCT05400863 is a clinical study titled "Effect of NNS on Metformin/GDF15, Pilot". Metformin use for diabetes has the benefit of causing weight loss in some. The investigators in a preclinical trial, demonstrated that mice consuming non-nutritive sweetened (NNS) drinks had worse glucose improvements and weight loss than mice consuming sugar drinks or water. This study will conduct...
What is the current status of trial NCT05400863?
This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2022-04-21. Estimated completion is 2024-08-02.
What interventions are being tested in trial NCT05400863?
The interventions under investigation include: avoid sugary and NNS drinks plus start Metformin (BEHAVIORAL), avoid sugary drinks (allowed water and drinks sweetened with NNS) plus start Metformin (BEHAVIORAL).
Who is sponsoring clinical trial NCT05400863?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.